Osteoarthritis & MBST® Technology

Osteoarthritis is a common cause of pain

Osteoarthritis is one of the UK's most common chronic degenerative joint diseases. It affects around one third of those aged 45 and over and is more likely to develop as you age, according to BUPA. It is characterised by the breakdown of joint cartilage. It can occur in any joint, commonly affecting the hands, knees, hips and spine. While many sporting professionals or highly active individuals can suffer from osteoarthritis, it can affect adults from any walk of life.

Wear & Tear Arthritis

Articular surfaces are covered in hyaline cartilage, which is super smooth and helps the joints move well. Over time the cartilage thins, and the joint space reduces affecting joint mobility. This can result in pain, stiffness and swelling. Ultimately, it limits activity. Hyaline cartilage cells are typically slow to form and do not regrow, but are replaced by mechanically inferior fibrous cartilage. Osteoarthritis can inhibit the process of repair and the joint cartilage becomes less resilient to normal wear. You can read more about the causes of Osteoarthritis from Arthritis Action here.

Treatment for Osteoarthritis

Most treatments for osteoarthritis treat the symptoms, but do not address the process. Intra-articular injections, traditional painkillers, topical pain relief and even nerve inhibiting surgery are often combined with physiotherapy to relieve the painful symptoms. These measures do nothing to stop the progression of the disease. MBST® therapy as a physiotherapy treatment modality is non-invasive and pain free.  It is designed to stimulate normal cell function in the affected area to slow down the progression of osteoarthritis and reduce the pain and inflammation associated with the condition, ultimately making activity more comfortable. 

MBST® therapy and Osteoarthritis

MBST® magnetic resonance therapy has been evidenced to help patients suffering from arthritic conditions, in particular osteoarthritis. During MBST® treatment, energy interacts with hydrogen protons to help stimulate normal cell function. It also down regulates Interleukin-1 (anti-inflammatory marker) reducing inflammation which is detrimental to osteoarthritis.

Safety of MBST® therapy

Recently the National Institute for Health and Care Excellence (NICE) have reported no safety concerns associated with magnetic resonance therapy for knee osteoarthritis and following a recent scoping study by the College of Radiographers, which found reduced pain and improved mobility in patients with osteoarthritis following a course of magnetic resonance therapy treatment, medical professionals are embracing the benefits of MBST®  technology in support of such conditions in the UK.  

‍